ALGS Q1 2026 Earnings NarrowerThanExpected Loss as Aligos Therapeutics Advances Pipeline SRXH Q2 2025 Earnings EPS Loss of 074 Amidst Stock Decline RRBI Q1 2026 Earnings Solid EPS Beat Amid Slight Stock Decline ASRV Q1 2026 Earnings Positive EPS Reported Amid Quiet Quarter GROV Q1 2026 Earnings Significant EPS Beat Amid Cost Discipline Unifi Inc UFI Climbs 15 as Shares Approach Key Resistance at 424 Vicor Corporation VICR Surges Over 24 Testing Key Resistance After Powerful Rally Weyerhaeuser WY Edges Higher Testing Key Resistance Near 2484 PSQ Holdings Inc PSQH Slides Amid Consolidation Key Support and Resistance Levels in Focus INLX Q1 2026 Earnings Significant EPS Miss Highlights Operational Headwinds EML Q1 2026 Earnings Significant EPS Miss Despite Stable Stock Performance Under Armour Q1 2026 Earnings EPS Misses Estimates Amid Ongoing Restructuring JACK Q1 2026 Earnings EPS Slightly Misses Estimates but Stock Surges Over 8 CUK Q1 2026 Earnings EPS Misses Estimate but Stock Rallies on Operational Momentum ARTL Q4 2025 Earnings Narrowing Loss Surprises but Revenue Remains Absent STT Q1 2026 Earnings Strong EPS Beat Amid Market Uncertainty Ernexa Therapeutics ERNA Q3 2023 Earnings ClinicalStage Biotech Reports Net Loss as Stock Declines